Evidence map›Paper›PMID 22305620›Full record

ArticleVirology2012

An intermediate dose of LCMV clone 13 causes prolonged morbidity that is maintained by CD4+ T cells.

Andrew Stamm, Laura Valentine, Rashaun Potts, Mary Premenko-Lanier

Open access · greenAbstract read
In one paragraph

Article in Virology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Chikungunya Virus Evades Antiviral CD8Journal of virology · 2020
    Article
  11. Article
  12. CD8Nature immunology · 2019
    Article
  13. Tim-3 co-stimulation promotes short-lived effector T cells, restricts memory precursors, and is dispensable for T cell exhaustion.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  14. Article
  15. Article
  16. The microRNA miR-31 inhibits CD8Nature immunology · 2017
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Andrew StammUniversity of California San Francisco, Division of Experimental Medicine, San Francisco, CA 94110, USA.
Laura Valentine
Rashaun Potts
Mary Premenko-Lanier
University of California, San Francisco · USSan Francisco State University · US

Funding

UCSF CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR024131 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHNSTON, S. CLAIBORNE · 2006 to 2011
$111.2M
SFSU MBRS - RISER25GM059298 · NIGMS · SAN FRANCISCO STATE UNIVERSITY · PI BAIRD, TEASTER T, BAYLISS, FRANK T · 1999 to 2021
$21.0M
Preventing and Curing Persistent Infections with Transient FTY720 TreatmentR00AI076346 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PREMENKO-LANIER, MARY F · 2009 to 2010
$498k
NCRR NIH HHS UL1 RR024131NIAID NIH HHS R00 AI076346NIAID NIH HHS R00 AI076346-01NIGMS NIH HHS R25 GM059298
6 · The paper itself

Abstract

Wasting is a sign of various underlying disorders and is a common feature of cancer, sepsis, and AIDS. We have developed an in vivo model to study the various stages of wasting following infection of mice with lymphocytic choriomeningitis virus cl-13. Using this model we have identified four distinct stages of wasting and have discovered that all stages occur in the different groups of mice regardless of whether the virus is cleared or persists. However, the degree and extent of wasting vary between groups of mice, depending upon the dose of virus administered. Blocking IFNγ or TNFα, which are believed to take part in the wasting process, did not affect the wasting state. Finally, we found that CD4+ T cells control the maintenance stage of wasting. We believe this model will be useful in studying the regulation of wasting during a persistent viral infection, hopefully leading to improved therapies to ameliorate the disorder.

Indexed as

AnimalsCD4-Positive T-LymphocytesFemaleHumansLymphocytic ChoriomeningitisLymphocytic choriomeningitis virusMiceMice, Inbred C57BL

Identifiers

PMID22305620
PMCPMC3288322
OpenAlexW2078251245

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.